Stocks to Watch for February 24: Bharti Airtel, BPCL, Lupin and more
Published on 23/02/2026 06:01 PM
From Bharti Airtel planning to capitalise its NBFC arm with ₹20,000 crore to drug firm Lupin receiving approval from the European Commission for its biosimilar ranibizumab, these are some of the stocks to watch out ahead of Tuesday's trading session.Lupin | The drug firm received approval from the European Commission for its biosimilar ranibizumab, Ranluspec (for vials and pre-filled syringes).BPCL | The state-owned refiner has received an order from the Commissioner of Central Tax and Central Excise, Kochi, confirming a total excise demand of ₹1,816.65 crore.Bharti Airtel | The communications solutions provider firm announced plans to capitalise its NBFC arm, Airtel Money Limited, with ₹20,000 crore over the next few years.Patel Engineering | The infrastructure company, in a joint venture, has been declared the lowest bidder for an irrigation project of ₹133.25 crore from Maharashtra Krishna Valley Development Corporation. Patel Engineering's share in the contract is ₹67.96 crore.HFCL | The technology company has joined a consortium for a Department of Telecommunications -funded research project led by Indian IIT Delhi to advance hollow-core fiber (HCF) technology for next-generation communication networks.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.